Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects

BACKGROUND: Efforts to ease administration and enhance acceptability of the oral anti-malarial artemether-lumefantrine (A-L) crushed tablet to infants and children triggered the development of a novel dispersible tablet of A-L. During early development of this new formulation, two studies were perfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulla, Salim, Amuri, Baraka, Kabanywanyi, Abdunoor M, Ubben, David, Reynolds, Christine, Pascoe, Steve, Fitoussi, Serge, Yeh, Ching-Ming, Nuortti, Marja, Séchaud, Romain, Kaiser, Günther, Lefèvre, Gilbert
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945360/
https://www.ncbi.nlm.nih.gov/pubmed/20815879
http://dx.doi.org/10.1186/1475-2875-9-253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945360/
https://www.ncbi.nlm.nih.gov/pubmed/20815879
http://dx.doi.org/10.1186/1475-2875-9-253

Ejemplares similares